LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

GlyT-1 inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

GlyT1 receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

GlyT2 modulators

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

GM-95-containing antitumor effect potentiator, combined...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH analogs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH analogs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH analogs for destroying gonadotrophs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH antagonist decapeptides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH Antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH antagonists being modified in positions 5 and 6

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GNRH antagonists IIIB

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH Antagonists IV

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH antagonists IX

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH Antagonists VI

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH antagonists VII

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GnRH antagonists VIII

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

GNRH antagonists XIII

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Gonadoliberin antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Gonadoliberin derivatives and process for the preparation thereo